Literature DB >> 26994693

An integrated overview on pyrrolizines as potential anti-inflammatory, analgesic and antipyretic agents.

Ahmed M Gouda1, Ahmed H Abdelazeem2.   

Abstract

Despite the existence of huge number of NSAIDs, the quest for safer drugs is still in the focus of several drug discovery programs. Pyrrolizine heterocyclic system is among the privileged scaffolds utilized in this regard. At least one of these pyrrolizines, ketorolac, has reached the market. The current review represents a collective effort to highlight the reported pyrrolizines with anti-inflammatory and analgesic potential and categorize them into eight different classes. Furthermore, the various synthetic approaches, structure-activity relationship as well as metabolic pathways have been discussed. Taken together, this review sets a base for researchers to design and synthesize novel pyrrolizine-based libraries for further development into safer and efficient anti-inflammatory and analgesic agents.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; COX/5-LOX dual inhibitors; Ketorolac; Licofelone; NSAIDs; Pyrrolizine; SFZ-47

Mesh:

Substances:

Year:  2016        PMID: 26994693     DOI: 10.1016/j.ejmech.2016.01.055

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Photochemical Csp2-H bond thiocyanation and selenocyanation of activated arenes, batch and continuous-flow approaches.

Authors:  Ignacio D Lemir; Gabriela Oksdath-Mansilla; Willber D Castro-Godoy; Luciana C Schmidt; Juan E Argüello
Journal:  Photochem Photobiol Sci       Date:  2022-02-03       Impact factor: 4.328

2.  In Silico Approach Using Free Software to Optimize the Antiproliferative Activity and Predict the Potential Mechanism of Action of Pyrrolizine-Based Schiff Bases.

Authors:  Faisal A Almalki; Ashraf N Abdalla; Ahmed M Shawky; Mahmoud A El Hassab; Ahmed M Gouda
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.